Opioid Substitution Treatment
4
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
10 treatments under study, led by Ketorolac
Research Leaders
6 sponsors active, led by Mundipharma Research Limited
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
25%
1 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
Opioids, Low Nicotine Cigarettes, and Chronic Pain
ICE-T Pain Regimen for Total Laparoscopic Hysterectomy
Content and Expectations of Consultations of Patients With Opioid Substitution Treatment Considered as Stabilized: Cross-Testimonials Doctors - Patients (MSOSuiStab)
Study to Assess Pharmacokinetic (PK), Bioavailability & Food Effect of MR902 Compared With Immediate Release (IR) Morphine Sulphate Oral Solution
Research Network
Common Treatments
- Ketorolac1
- Normal Nicotine Cigarettes Nnc1
- Oxycodone1
- Semidirected Interviews1
- Very Low Nicotine Cigarettes Vlnc1
Active Sponsors
- Mundipharma Research Limited1
- National Institutes of Health (NIH)1
- University Hospital, Angers1
- MetroHealth Medical Center1
- Duke University1
Top Investigators
Duke University
MetroHealth Medical Center
Related Conditions
- Chronic Pain1
- Tobacco Use1